2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read moreACR® joined a multisociety initiative opposing proposed Local Coverage Determinations (LCDs) that would significantly restrict Medicare coverage for peripheral nerve blocks and related procedures used to treat chronic pain.
These LCD policies threaten patient access to evidence-based, opioid-sparing treatments and contradict federal efforts to reduce opioid reliance.
ACR co-signed letters submitted by the Society of Interventional Radiology and the Multisociety Pain Workgroup to five Medicare Administrative Contractors, urging them to rescind the proposed LCDs.
“Restrictive LCDs risk undermining CMS’s opioid reduction goals by eliminating access to proven non-opioid therapies,” the letters state. The ACR Contractor Advisory Committee Network and the Commission on Interventional and Cardiovascular Imaging have reviewed the proposals and voiced opposition.
Key concerns include:
For more information, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read morePhysician Groups Warn Visa Delays Could Impact Patient Care
More than 30 medical organizations, including the ACR®️, urged federal officials to address immigration barriers preventing international medical graduates (IMGs) from lawfully entering or remaining in the U.S.
Read moreACR Submits Testimony to Congress
ACR®️ submitted testimony to the U.S. House Committee on Appropriations Labor urging strong federal funding for medical research in federal fiscal year 2027.
Read more